FDA Inspection
Emerson HospitalEmerson Hospital – FDA Inspection, Feb 4, 2019
Record Details
This FDA Inspection record concerns Emerson Hospital, with an inspection on February 4, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Person
- Alice C. Silva (Issuing Officer)
View Company Profile
ID · 747202e3-7931-4379-90ab-38a72a275a0c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1078912
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 610.53(b)Dating periods for licensed biological products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Emerson Hospital
9| Date | Classification | Office | Project area |
|---|---|---|---|
| August 6, 2025 | VAI | New England District Office | Blood and Blood Products |
| March 30, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 13, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 13, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 13, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Emerson Hospital
- FDA Inspection 1277644 - 2025-08-06
- FDA Inspection 1202980 - 2023-03-30
- FDA Inspection 1010013 - 2017-04-13
- FDA Inspection 916284 - 2015-01-13
- FDA Inspection 822790 - 2013-03-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.